Interferon gamma induction during oral tolerance reduces T-cell migration to sites of inflammation

Gastroenterology

Volumn 119, Issue 1, 2000, Pages 129-138

  Lee, Hae Ock ^a   Miller, Stephen D ^a   Hurst, Stephen D ^b   Tan, Lit Jen ^a   Cooper, Cristine J ^a   Barrett, Terrence A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; INTERFERON PRODUCTION; LYMPHOCYTE MIGRATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0034235362     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.8542     Document Type: Article

References (44)

1. Chen Y, Inobe J, Weiner HL. Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell Immunol 1997;178:62-68.
2. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice: Systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol 1996;157:2348-2357.
3. Hurst SD, Sitterding SM, Ji S, Barrett TA. Functional differentiation of T cells in the intestine of T cell receptor transgenic mice. Proc Natl Acad Sci U S A 1997;94:3920-3925.
4. + T cells from alpha beta T cell receptor-transgenic mice: A distinct mucosal cytokine phenotype in the absence of transgene-specific antigen. Eur J Immunol 1997;27:1774-1781.
5. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.J Immunol 1996;157:1261-1270.
6. Xu-Amano J, Aicher WK, Taguchi T, Kiyono H, McGhee JR. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int Immunol 1992;4:433-445.
7. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A 1994;91:6688-6692.
8. Miller A, Lider O, Weiner HL. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 1991;174: 791-798.
9. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
10. Melamed D, Friedman A. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 1993;23:935-942.
11. Melamed D, Friedman A. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: Anergy in the absence of suppression. Eur J Immunol 1994;24:1974-1981.
12. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991;147:2155-2163.
13. Van Houten N, Blake SF. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 1996;157:1337-1341.
14. + T cells during initiation of infection. J Exp Med 1994;179:447-456.
15. Farrar MA, Schreiber RD. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 1993;11:571-611.
16. Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J Immunol 1993;23:333-337.
17. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, Caspi RR. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 1999;189:219-230.
18. Matthys P, Heremans H, Dillen C, Billiau A. Effects of interferon-γ and anti-IFN-γ antibodies on experimental arthritis in mice (abstr). J Interferon Res 1989;9S:130.
19. Duong TT, St. Louis J, Gilbert JJ, Finkelman FD, Strejan GH. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal anti-body treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J Neuroimmunol 1992;36:105-115.
20. Spiekermann GM, Nagler-Anderson C. Oral administration of the bacterial superantigen staphylococcal enterotoxin B induces activation and cytokine production by T cells in murine gut-associated lymphoid tissue. J Immunol 1998;161:5825-5831.
21. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-339.
22. +TCRIo thymocytes in vivo. Science 1990;250:1720-1723.
23. Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987;166:1229-1244.
24. Miller SD, Wetzig RP, Claman HN. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med 1979;149:758-773.
25. Mowat AM, Donachie AM, Reid G, Jarrett O. Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 1991;72:317-322.
26. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749-795.
27. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-66.
28. Billiau A. Interferon-gamma: Biology and role in pathogenesis. Adv Immunol 1996;62:61-130.
29. Svanborg C, Godaly G, Hedlund M. Cytokine responses during mucosal infections: Role in disease pathogenesis and host defence. Curr Opin Microbiol 1999;2:99-105.
30. Yoong KF, Afford SC, Jones R, Aujla P, Qin S, Hubscher SG, Adams DH. Expression and function of CXC and CC chemokines in human malignant liver tumors: A role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology 1999;30:100-111.
31. Kopydlowski KM, Salkowski CA, Cody MJ, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 1999;163:1537-1544.
32. Goes N, Sims T, Urmson J, Vincent D, Ramasser V, Halloran PF. Disturbed MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma. J Immunol 1995;155:4559-4566.
33. Kweon MN, Fujihashi K, VanCott JL, Higuchi K, Yamamoto M, McGhee JR, Kiyono H. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice. J Immunol 1998;160: 1687-1693.
34. Shi HN, Grusby MJ, Nagler-Anderson C. Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J Immunol 1999;162:5143-5148.
35. Kjerrulf M, Grdic D, Ekman L, Schon K, Vajdy M, Lycke NY. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology 1997;92:60-68.
36. Zhang ZY, Michael JG. Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment. J Immunol 1990;144: 4163-4165.
37. Mowat AM, Steel M, Leishman AJ, Garside P. Normal induction of oral tolerance in the absence of a functional IL-12-dependent IFN-γ signaling pathway. J Immunol 1999;163:4728-4736.
38. Duong TT, Finkelman FD, Singh B, Strejan GH. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J Neuroimmunol 1994;53:101-107.
39. Billiau A, Heremans H, Vandekerckhove F, Dijkmans R, Sobis H, Meulepas E, Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 1988;140:1506-1510.
40. Heremans H, Dillen C, Groenen M, Martens E, Billiau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: Enhancement by monoclonal antibodies against interferon-gamma. Eur J Immunol 1996;26:2393-2398.
41. Voorthuis JA, Uitdehaag BM, De Groot CJ, Goede PH, van der Meide PH, Dijkstra CD. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 1990;81:183-188.
42. - cells and interferon gamma. J Exp Med 1997;186:71-81.
43. Caspi RR, Stiff LR, Morawetz R, et al. Cytokine-dependent modulation of oral tolerance in a murine model of autoimmune uveitis. Ann N Y Acad Sci 1996;778:315-324.
44. Yoshino S. Treatment with an anti-Il-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen. J Immunol 1998;160:3067-3071.